Laboratory-Confirmed COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Omicron BA.2 Variant Predominance — COVID-19–Associated Hospitalization Surveillance Network, 14 States, June 20, 2021

Laboratory-Confirmed COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Omicron BA.2 Variant Predominance — COVID-19–Associated Hospitalization Surveillance Network, 14 States, June 20, 2021–May 31, 2022

Published:2022-08-26 Issue:34 Volume:71 Page:1085-1091
ISSN:0149-2195
Container-title:MMWR. Morbidity and Mortality Weekly Report
language:
Short-container-title:MMWR Morb. Mortal. Wkly. Rep.

Author:

Havers Fiona P.,Patel Kadam,Whitaker Michael,Milucky Jennifer,Reingold Arthur,Armistead Isaac,Meek James,Anderson Evan J.,Weigel Andy,Reeg Libby,Seys Scott,Ropp Susan L.,Spina Nancy,Felsen Christina B.,Moran Nancy E.,Sutton Melissa,Talbot H. Keipp,George Andrea,Taylor Christopher A.,Daily Kirley Pam,Alden Nisha B.,Yousey-Hindes Kimberly,Openo Kyle P.,Brown Chloe,Schardin Cody T.,Plymesser Kelly,Barney Grant,Popham Kevin,Billing Laurie M.,Abdullah Nasreen,Markus Tiffanie M.,Hill Mary, ,

Publisher

Centers for Disease Control MMWR Office

Subject

Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health (social science),Epidemiology

Reference6 articles.

1. Summary of guidance for minimizing the impact of COVID-19 on individual persons, communities, and health care systems—United States, August 2022.;Massetti;MMWR Morb Mortal Wkly Rep,2022

2. COVID19-associated hospitalizations among vaccinated and unvaccinated adults ≥18 years—COVID-NET, 13 states, January 1, 2021–April 30, 2022.;Havers;JAMA Intern Med,2022

3. Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19—COVID-NET, 13 States, March 1–August 22, 2020.;Delahoy;MMWR Morb Mortal Wkly Rep,2020

4. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019—COVID-NET, 14 States, March 1–30, 2020.;Garg;MMWR Morb Mortal Wkly Rep,2020

5. Effectiveness of 2, 3, and 4 COVID-19 mRNA vaccine doses among immunocompetent adults during periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 sublineages predominated—VISION Network, 10 states, December 2021–June 2022.;Link-Gelles;MMWR Morb Mortal Wkly Rep,2022

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of COVID-19 in pediatric population and the effects of COVID-19 vaccination: A retrospective cohort study;Auris Nasus Larynx;2024-06

2. Social and Structural Determinants of Health Associated with COVID-19 Vaccine Hesitancy among Older Adults in the United States;Vaccines;2024-05-10

3. What Is the Economic Benefit of Annual COVID-19 Vaccination From the Adult Individual Perspective?;The Journal of Infectious Diseases;2024-04-06

4. How the Timing of Annual COVID-19 Vaccination of Nursing Home Residents and Staff Affects Its Value;Journal of the American Medical Directors Association;2024-04

5. COVID-19 vaccines: Immune correlates and clinical outcomes;Human Vaccines & Immunotherapeutics;2024-03-22